RxDoctor Payments Data

Mark Woolley, DPM

Foot & Ankle Surgery · South Ogden, UTNPI 1629213780

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (42.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Active Medical, LLC at 43.8% of the total. Reporting peaked in 2021 at $4,029 and has fallen 91.1% since, to $358 in 2025.

$5,650in general payments, 2019–2025

Across 61 payments — averaging $92.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Active Medical, LLC$2K
  • Arthrex$1K
  • Treace Medical Concepts, Inc.$610
  • Stryker$214
  • Orthofix Medical, Inc.$106
  • Smith+Nephew$81
  • plus $667 from 22 others

What the payments were for

  • Travel & lodging$1,70530%
  • Food & beverage$1,54527%
  • Education$2,40042%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,650 in reported general payments places this provider in the 65th percentile of 104 foot & ankle surgery providers in Utah.

See all foot & ankle surgery providers in Utah

Medicare billing

Part B allowed, 2024
$186,189
Medicare patients
328
Services billed
1,936

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl35$790
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$377
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$271
Celecoxib17$265
Cephalexin28$158
Methylprednisolone16$146
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$88
Meloxicam29$69
Silver Sulfadiazine15$65

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in South Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →